Above Rs 440, Ranbaxy uptrend likely to be over: Bothra - Stocks Views
Short Ranbaxy Lab, Adani Enterprises: SP Tulsian - Stocks Views
Lupin may correct to Rs 725-730: SP Tulsian - Stocks Views
Buy Lupin only on deeper correction: Sukhani - Stocks Views
Drug prices set to get cheaper, pharma cos worry - CNBC-TV18 Comments
Avoid buying Lupin, says Sudarshan Sukhani - Stocks Views
i am not sure why this bra_ndi...>
- Survey likely to peg FY12 GDP growth at 9%
- SBI plans merger of 5 associate banks in next 12-18 months
- How is Libya impacting global oil prices?
- Nifty ends lower as oil hits USD 96/bbl
- Oberoi Realty in talks with HDIL for TDR purchase: Sources
- RBI releases draft norms on CDS in corp bonds
- Citigroup likely to hike global IT budgets for `12:
- Anil Ambani meets Maharashtra CM
- Realty check: How are experts reading the space?